Stephanie Cox

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

Colleen F. Kelley, Maribel Acevedo-Quiñones, Allison L. Agwu et al. · New England Journal of Medicine · 2024 · 169 citations

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +9

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer et al. · The Lancet HIV · 2021 · 88 citations · Full text

Preventive Medicine, Week 96, Treatment And Prevention +10

Agreement between Automated and Traditional Measures of Tear Film Breakup

Stephanie Cox, Kelly K. Nichols, Jason J. Nichols · Optometry and Vision Science · 2015 · 67 citations · Full text

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection

Andrea L. Cathcart, Henry Lik‐Yuen Chan, Neeru Bhardwaj et al. · Antimicrobial Agents and Chemotherapy · 2018 · 59 citations · Full text